Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1978 2
1979 1
1983 3
1984 1
1985 1
1986 1
1987 1
1988 3
1989 2
1990 5
1991 5
1992 2
1993 1
1994 1
1995 1
1996 3
1997 6
1998 3
1999 5
2000 7
2001 2
2002 7
2003 7
2004 13
2005 8
2006 11
2007 6
2008 13
2009 6
2010 12
2011 13
2012 10
2013 12
2014 12
2015 20
2016 18
2017 17
2018 13
2019 13
2020 18
2021 18
2022 20
2023 18
2024 16
2025 16
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Heuvelhof
Page 1
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval …
Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-cent …
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Ernst M, Oeser A, Besiroglu B, Caro-Valenzuela J, Abd El Aziz M, Monsef I, Borchmann P, Estcourt LJ, Skoetz N, Goldkuhle M. Ernst M, et al. Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2. Cochrane Database Syst Rev. 2021. PMID: 34515338 Free PMC article.
We also identified 38 ongoing studies, including three RCTs. Ten studies are awaiting classification due to completion with no retrievable results data or insufficient data to justify inclusion. ...
We also identified 38 ongoing studies, including three RCTs. Ten studies are awaiting classification due to completion with no retrie …
Biallelic NAA60 variants with impaired n-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications.
Chelban V, Aksnes H, Maroofian R, LaMonica LC, Seabra L, Siggervåg A, Devic P, Shamseldin HE, Vandrovcova J, Murphy D, Richard AC, Quenez O, Bonnevalle A, Zanetti MN, Kaiyrzhanov R, Salpietro V, Efthymiou S, Schottlaender LV, Morsy H, Scardamaglia A, Tariq A, Pagnamenta AT, Pennavaria A, Krogstad LS, Bekkelund ÅK, Caiella A, Glomnes N, Brønstad KM, Tury S, Moreno De Luca A, Boland-Auge A, Olaso R, Deleuze JF, Anheim M, Cretin B, Vona B, Alajlan F, Abdulwahab F, Battini JL, İpek R, Bauer P, Zifarelli G, Gungor S, Kurul SH, Lochmuller H, Da'as SI, Fakhro KA, Gómez-Pascual A, Botía JA, Wood NW, Horvath R, Ernst AM, Rothman JE, McEntagart M, Crow YJ, Alkuraya FS, Nicolas G; SYNaPS Study Group; Arnesen T, Houlden H. Chelban V, et al. Nat Commun. 2024 Mar 13;15(1):2269. doi: 10.1038/s41467-024-46354-0. Nat Commun. 2024. PMID: 38480682 Free PMC article.
Here, we identify biallelic NAA60 variants in ten individuals from seven families with autosomal recessive PFBC. The NAA60 variants lead to loss-of-function with lack of protein N-terminal (Nt)-acetylation activity. ...
Here, we identify biallelic NAA60 variants in ten individuals from seven families with autosomal recessive PFBC. The NAA60 variants l …
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. NIHR Global Health Research Unit on Global Surgery, et al. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7. Lancet Digit Health. 2024. PMID: 38906616 Free PMC article.
Penalised regression using LASSO had similar discrimination to XGBoost (area under the receiver operating curve [AUROC] 0.786, 95% CI 0.774-0.798 vs 0.785, 0.772-0.797), was more explainable, and required fewer covariables. The final GSU-Pulmonary Score included ten predic …
Penalised regression using LASSO had similar discrimination to XGBoost (area under the receiver operating curve [AUROC] 0.786, 95% CI 0.774- …
Liposuction versus conservative therapy for patients with lipoedema in Germany: a multicentre, randomised controlled clinical trial.
Podda M, Schmidt J, Cornely ME, Steinmetz MI, Rajewski D, Busch KH, Taufig Z, Ghods M, Kovacs M, Schmid S, Kraus D, Hellmich M, Müller W, Schiller P, Cornely OA. Podda M, et al. Lancet. 2026 Sep 5;408(10558):910-923. doi: 10.1016/S0140-6736(26)00910-4. Lancet. 2026. PMID: 42692034 Free article. Clinical Trial.
After 12 months, 190 (68%) of 278 randomisly assigned patients undergoing liposuction achieved the primary endpoint of pain reduction versus ten (8%) of 132 randomly assigned to conservative therapy (odds ratio 26.2 [95% CI 13.1-52.5]; p<0.0001). ...
After 12 months, 190 (68%) of 278 randomisly assigned patients undergoing liposuction achieved the primary endpoint of pain reduction versus …
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Siegert E, Phithak E, Albach FN, Biesen R, Drzeniek NM, Dzamukova M, Haase I, Søndergaard K, Schleser D, Fiebig L, Sattler A, Minopoulou I, Rehm MC, Kremer P, Schneider U, Trezzini S, Rein AMC, Mayer CM, Doellinger F, Furth C, Staeck A, Cheng Q, Sinzinger B, Unterwalder N, Ohrndorf S, Probst M, Li Y, Grund D, Walter-Rittel T, Fleischmann A, Wiebe E, Hütter-Krönke ML, Keller U, Krönke J, Busse A, Kleyer A, Pecher AC, Henes J, Troldborg A, Hauser AE, Kötter I, Krusche M, Krönke G, Alexander T, Simon D. Siegert E, et al. Ann Rheum Dis. 2026 Jun 18:S0003-4967(26)00301-8. doi: 10.1016/j.ard.2026.05.023. Online ahead of print. Ann Rheum Dis. 2026. PMID: 42315474 Free article.
Clinical efficacy was assessed using the American College of Rheumatology Composite Response Index in Systemic Sclerosis (ACR-CRISS) responses, among others. RESULTS: Ten patients with SSc (70% female; median age 51 years [IQR: 7]) completed 1 cycle of teclistamab. ...
Clinical efficacy was assessed using the American College of Rheumatology Composite Response Index in Systemic Sclerosis (ACR-CRISS) respons …
How Cryo-EM Revolutionized the Field of Bioenergetics.
Sottatipreedawong M, Kazmi AA, Vercellino I. Sottatipreedawong M, et al. Microsc Microanal. 2025 Feb 17;31(1):ozae089. doi: 10.1093/mam/ozae089. Microsc Microanal. 2025. PMID: 39298136 Free article. Review.
Ten years ago, the term "resolution revolution" was used for the first time to describe how cryogenic electron microscopy (cryo-EM) marked the beginning of a new era in the field of structural biology, enabling the investigation of previously unsolvable protein targets. .. …
Ten years ago, the term "resolution revolution" was used for the first time to describe how cryogenic electron microscopy (cryo-EM) m …
Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
Vetter VC, Wagner E. Vetter VC, et al. J Control Release. 2022 Jun;346:110-135. doi: 10.1016/j.jconrel.2022.04.013. Epub 2022 Apr 21. J Control Release. 2022. PMID: 35436520 Review.
The current medical reality of cancer gene therapy is reflected by more than ten approved products on the global market, including oncolytic and other viral vectors and CAR T-cells as ex vivo gene-modified cell therapeutics. ...
The current medical reality of cancer gene therapy is reflected by more than ten approved products on the global market, including on …
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, Van Gelder M, Junghanß C, Gahrton G, Hänel M, Hehlmann R, Heinicke T, Hochhaus A, Iacobelli S, Kooy RVM, Kröger N, Janssen J, Jentzsch M, Breywisch F, Mohty M, Masouridi-Levrat S, Ossenkoppele G, Passweg J, Pönisch W, Schetelig J, Schliemann C, Schwind S, Stelljes M, Verdonck LF, Vucinic V, Löwenberg B, Cornelissen J. Niederwieser D, et al. Haematologica. 2025 Jan 1;110(1):68-77. doi: 10.3324/haematol.2024.285879. Haematologica. 2025. PMID: 39113672 Free PMC article. Clinical Trial.
Of the 179 (73%) patients still on study, 75.4% had an HLA identical donor. Ten ineligible patients were excluded, and 125 randomized to HCT (N=83) or non-HCT (N=42). ...
Of the 179 (73%) patients still on study, 75.4% had an HLA identical donor. Ten ineligible patients were excluded, and 125 randomized …
Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial.
Fischer U, Brehm A, Ribo M, Rizzo F, Strbian D, Räty S, Arenillas JF, Martínez-Galdámez M, Hajdu SD, Michel P, Gralla J, Piechowiak EI, Kaiser DPO, Puetz V, Van den Bergh F, De Raedt S, Bellante F, Dusart A, Hellstern V, Khanafer A, Parrilla G, Morales A, Kirschke JS, Wunderlich S, Fiehler J, Thomalla G, Lemmens R, Peluso JP, Bolognese M, von Hessling A, van Es A, Kruyt ND, Coutinho JM, Castaño C, Minnerup J, van Zwam W, Dhondt E, Nolte CH, Machi P, Loehr C, Mattle HP, Buhk JH, Kaesmacher J, Dobrocky T, Papanagiotou P, Alonso A, Holtmannspoetter M, Zini A, Renieri L, Keil F, van den Wijngaard I, Kägi G, Terceño M, Wiesmann M, Amaro S, Fragata I, Katan M, Leker RR, Saver JL, Staals J, Rommers N, Balmer L, Psychogios M; DISTAL investigators. Fischer U, et al. Lancet Neurol. 2026 Jun;25(6):571-580. doi: 10.1016/S1474-4422(26)00169-9. Epub 2026 May 6. Lancet Neurol. 2026. PMID: 42105785 Free article. Clinical Trial.
FINDINGS: Between Dec 16, 2021, and July 10, 2024, we enrolled 553 patients. Ten patients declined post-hoc consent, leaving 543 participants in the analysis (239 [44%] females and 304 [56%] males; median age 77 years, IQR 68-84). 271 (50%) were assigned to endovascular tr …
FINDINGS: Between Dec 16, 2021, and July 10, 2024, we enrolled 553 patients. Ten patients declined post-hoc consent, leaving 543 part …
344 results